alexa Aspirin---the novel antiplatelet drug.

Author(s): Pawar D, Shahani S, Maroli S

Abstract Share this page

Abstract Aspirin is a non-steroidal anti-inflammatory drug that has potent antiplatelet actions. Aspirin was initially used as an analgesic and antipyretic drug before its anti-inflammatory properties were discovered. Aspirin also has antithrombotic effects due to the inhibition of cyclo- oxygenase activity in platelets, which reduces the extent of thromboxane A2 formation and consequently the aggregability of platelets. Prophylactic low-dose aspirin therapy reduces the risk of future cardiovascular events in a variety of clinical settings. The maximum effect of aspirin in reducing risks of myocardial infarction is achieved soon after the initiation of therapy. The selective inhibition of platelet thromboxane A2 may be the pharmacological basis for the effectiveness of aspirin in treating pregnancy-induced hypertension. Aspirin can virtually abolish thromboxane A2 production in patients receiving fish oil. Thus, aspirin has been and will be the standard reference compound for long-term oral treatment of platelet hyperactivity, most notably in the secondary prevention of myocardial infarction.
This article was published in Hong Kong Med J and referenced in

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Recommended Journals

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords